8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Feb 6, 2026·SEC
Material company update
Jan 29, 2026·SEC
Dolby Laboratories, Inc.(DLB)Earnings, Financials & Key Ratios
DLB•NYSE
20.0× P/E·Price updated Jun 19, 2026
AboutDolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.Show more
- Revenue$1.35B+5.9%
- EBITDA$364M+3.3%
- Net Income$255M-2.6%
- EPS (Diluted)2.62-2.6%
- Gross Margin88.13%-0.9%
- EBITDA Margin26.95%-2.5%
- Operating Margin19.64%-5.5%
- Net Margin18.9%-8.0%
- ROE9.96%-7.5%
DLB Key Insights
Dolby Laboratories, Inc. (DLB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓FCF machine: 31.9% free cash flow margin
- ✓12 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy dividend yield of 2.5%
- ✓Healthy 5Y average net margin of 18.8%
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when DLB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DLB Price & Volume
Dolby Laboratories, Inc. (DLB) stock price & volume — 10-year historical chart
Loading chart...
DLB Growth Metrics
Dolby Laboratories, Inc. (DLB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years3.35%
5 Years3.04%
3 Years2.47%
TTM1.8%
Profit CAGR
10 Years3.47%
5 Years1.97%
3 Years11.48%
TTM-8.43%
EPS CAGR
10 Years4.24%
5 Years3.09%
3 Years13.12%
TTM-8.82%
Return on Capital
10 Years10.18%
5 Years10.18%
3 Years10.06%
Last Year9.63%
DLB Recent Earnings
Dolby Laboratories, Inc. (DLB) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$1.37+4.6%
$1.31
Rev
$396M+2.5%
$386M
Q1 2026
Jan 29, 2026Metric
Actual
Est
EPS
$1.06+6.7%
$0.99
Rev
$347M+1.6%
$341M
Q4 2025
Nov 18, 2025Metric
Actual
Est
EPS
$0.99+41.6%
$0.70
Rev
$307M+0.4%
$306M
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.78+9.2%
$0.71
Rev
$316M+3.2%
$306M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.37vs $1.31+4.6% | $396Mvs $386M+2.5% |
| Q1 2026 | Jan 29, 2026 | $1.06vs $0.99+6.7% | $347Mvs $341M+1.6% |
| Q4 2025 | Nov 18, 2025 | $0.99vs $0.70+41.6% | $307Mvs $306M+0.4% |
| Q3 2025 | Jul 31, 2025 | $0.78vs $0.71+9.2% | $316Mvs $306M+3.2% |
Based on last 12 quarters of dataView full earnings history →
DLB Peer Comparison
Dolby Laboratories, Inc. (DLB) competitors in Vertical Software and Industry Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 IRDM | 4.71B | 44.57 | 42.05 | 4.93% | 12.05% | 22.76% | 3.81 | |
 IPGP | 5.01B | 118.01 | 161.66 | 2.73% | 2.78% | 1.37% | ||
 QCOM | 238.32B | 226.11 | 45.13 | 13.66% | 22.31% | 40.19% | 0.77 | |
 IDCC | 7.62B | 296.04 | 25.09 | -3.97% | 44.2% | 33.37% | 0.46 | |
 VIA | 1.18B | 15.29 | -12.74 | 28.64% | -21.63% | -48.82% | 0.05 | |
 PLAB | 1.98B | 33.63 | 14.75 | -2.04% | 18.47% | 9.82% | 0.00 | |
 SONO | 1.77B | 14.68 | -28.78 | -4.93% | -2.82% | -10.43% | 0.17 | |
 LOGI | 15.45B | 107.64 | 22.43 | 6.28% | 14.69% | 32.22% |
Compare DLB vs Peers
Dolby Laboratories, Inc. (DLB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DLB Income Statement
Dolby Laboratories, Inc. (DLB) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 1.08B | 1.05B | 1.24B | 1.16B | 1.28B | 1.25B | 1.3B | 1.27B | 1.35B | 1.34B |
Revenue Growth % | 5.43% | -2.48% | 17.73% | -6.43% | 10.28% | -2.14% | 3.67% | -2% | 5.92% | 1.8% |
Cost of Goods Sold | 118.31M | 127.56M | 160.85M | 146.5M | 130.03M | 141.36M | 152.57M | 140.5M | 160.13M | 162.57M |
COGS % of Revenue | 10.94% | 12.1% | 12.96% | 12.61% | 10.15% | 11.27% | 11.74% | 11.03% | 11.87% | - |
Gross Profit | 963.15M▲ 0% | 927.04M▼ 3.7% | 1.08B▲ 16.6% | 1.02B▼ 6.1% | 1.15B▲ 13.4% | 1.11B▼ 3.4% | 1.15B▲ 3.1% | 1.13B▼ 1.2% | 1.19B▲ 4.9% | 1.18B▲ 0% |
Gross Margin % | 89.06% | 87.9% | 87.04% | 87.39% | 89.85% | 88.73% | 88.26% | 88.97% | 88.13% | 87.86% |
Gross Profit Growth % | 5.06% | -3.75% | 16.58% | -6.06% | 13.39% | -3.37% | 3.12% | -1.22% | 4.92% | - |
Operating Expenses | 701.66M | 743.98M | 787.13M | 794.73M | 810.47M | 895.21M | 884.36M | 868.51M | 924.04M | 924.82M |
OpEx % of Revenue | 64.88% | 70.55% | 63.4% | 68.41% | 63.26% | 71.4% | 68.04% | 68.19% | 68.49% | - |
Selling, General & Admin | 468.35M | 507.19M | 549.26M | 555.69M | 556.83M | 634.03M | 612.84M | 604.85M | 647.24M | 644.54M |
SG&A % of Revenue | 43.31% | 48.09% | 44.24% | 47.83% | 43.46% | 50.57% | 47.15% | 47.49% | 47.97% | - |
Research & Development | 233.31M | 236.79M | 237.87M | 239.04M | 253.64M | 261.17M | 271.52M | 263.66M | 261.79M | 264.23M |
R&D % of Revenue | 21.57% | 22.45% | 19.16% | 20.58% | 19.8% | 20.83% | 20.89% | 20.7% | 19.4% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.01M | 1.45M |
Operating Income | 261.49M▲ 0% | 183.06M▼ 30.0% | 293.63M▲ 60.4% | 220.56M▼ 24.9% | 340.76M▲ 54.5% | 217.23M▼ 36.3% | 262.81M▲ 21.0% | 264.71M▲ 0.7% | 264.96M▲ 0.1% | 251.45M▲ 0% |
Operating Margin % | 24.18% | 17.36% | 23.65% | 18.98% | 26.6% | 17.33% | 20.22% | 20.78% | 19.64% | 18.78% |
Operating Income Growth % | 12.21% | -29.99% | 60.4% | -24.89% | 54.5% | -36.25% | 20.99% | 0.72% | 0.09% | - |
EBITDA | 345.8M | 264.34M | 378.76M | 311.44M | 436.62M | 320.84M | 358.33M | 352.04M | 363.56M | 351.66M |
EBITDA Margin % | 31.98% | 25.07% | 30.51% | 26.81% | 34.08% | 25.59% | 27.57% | 27.64% | 26.95% | 26.27% |
EBITDA Growth % | 8.68% | -23.56% | 43.28% | -17.77% | 40.19% | -26.52% | 11.69% | -1.76% | 3.27% | -4.71% |
D&A (Non-Cash Add-back) | 84.31M | 81.28M | 85.12M | 90.88M | 95.86M | 103.61M | 95.51M | 87.33M | 98.6M | 100.21M |
EBIT | 256.64M | 196.37M | 282.31M | 239.72M | 354.51M | 215.28M | 250.05M | 312.48M | 279.97M | 270.59M |
Net Interest Income | 9.58M | 18.97M | 24.92M | 12.72M | 3.49M | 6.57M | 28.09M | 34.08M | 15.38M | 5.05M |
Interest Income | 9.58M | 18.97M | 24.92M | 12.72M | 3.49M | 6.57M | 28.09M | 34.08M | 15.38M | 9.17M |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.12M |
Other Income/Expense | -4.84M | 13.31M | -11.33M | 19.15M | 13.75M | -1.95M | -12.76M | 47.77M | 38.53M | 37.59M |
Pretax Income | 256.64M▲ 0% | 196.37M▼ 23.5% | 282.31M▲ 43.8% | 239.72M▼ 15.1% | 354.51M▲ 47.9% | 215.28M▼ 39.3% | 250.05M▲ 16.2% | 312.48M▲ 25.0% | 303.49M▼ 2.9% | 289.04M▲ 0% |
Pretax Margin % | 23.73% | 18.62% | 22.74% | 20.63% | 27.67% | 17.17% | 19.24% | 24.53% | 22.49% | 21.59% |
Income Tax | 54.22M | 154.07M | 26.8M | 8.1M | 36.69M | 31.38M | 48.41M | 48.16M | 46.99M | 46.93M |
Effective Tax Rate % | 21.13% | 78.46% | 9.49% | 3.38% | 10.35% | 14.58% | 19.36% | 15.41% | 15.48% | 16.24% |
Net Income | 201.8M▲ 0% | 41.75M▼ 79.3% | 255.15M▲ 511.2% | 231.36M▼ 9.3% | 310.23M▲ 34.1% | 184.09M▼ 40.7% | 200.66M▲ 9.0% | 261.82M▲ 30.5% | 255.02M▼ 2.6% | 240.52M▲ 0% |
Net Margin % | 18.66% | 3.96% | 20.55% | 19.91% | 24.21% | 14.68% | 15.44% | 20.56% | 18.9% | 17.97% |
Net Income Growth % | 8.58% | -79.31% | 511.2% | -9.32% | 34.09% | -40.66% | 9% | 30.48% | -2.6% | -8.43% |
Net Income (Continuing) | 202.43M | 42.3M | 255.5M | 231.62M | 317.82M | 183.9M | 201.64M | 264.32M | 256.49M | 242.1M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 7.1M | 6.57M | 5.68M | 5.76M | 6.25M | 4.84M | 17.08M | 9.73M | 9.39M | 9.2M |
EPS (Diluted) | 1.95▲ 0% | 1.14▼ 41.5% | 2.44▲ 114.0% | 2.25▼ 7.8% | 2.97▲ 32.0% | 1.81▼ 39.1% | 1.96▲ 8.3% | 2.69▲ 37.2% | 2.62▼ 2.6% | 2.49▲ 0% |
EPS Growth % | 7.73% | -41.54% | 114.04% | -7.79% | 32% | -39.06% | 8.29% | 37.24% | -2.6% | -8.82% |
EPS (Basic) | 1.98 | 1.18 | 2.51 | 2.30 | 3.07 | 1.84 | 2.00 | 2.74 | 2.66 | - |
Diluted Shares Outstanding | 103.29M | 106.98M | 104.57M | 102.94M | 104.62M | 101.98M | 97.59M | 97.33M | 97.48M | 96.52M |
Basic Shares Outstanding | 101.78M | 103.38M | 101.63M | 100.56M | 101.19M | 99.99M | 95.79M | 95.54M | 95.87M | 95.47M |
Dividend Payout Ratio | 28.27% | 158.47% | 30.37% | 38.29% | 28.74% | 54.36% | 51.53% | 43.76% | 49.64% | - |
DLB Balance Sheet
Dolby Laboratories, Inc. (DLB) balance sheet — assets, liabilities & shareholders' equity
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.01B | 1.3B | 1.38B | 1.55B | 1.76B | 1.31B | 1.49B | 1.19B | 1.39B | 1.41B |
Cash & Short-Term Investments | 882.13M | 1.1B | 924.74M | 1.13B | 1.27B | 817.58M | 957.11M | 577.75M | 702.6M | 644.58M |
Cash Only | 634.37M | 925.25M | 805.59M | 1.08B | 1.23B | 628.37M | 817.97M | 577.75M | 701.89M | 643.85M |
Short-Term Investments | 247.76M | 178.14M | 119.15M | 46.95M | 38.84M | 189.21M | 139.15M | 0 | 703K | 739K |
Accounts Receivable | 76.19M | 334.53M | 385.55M | 341.7M | 414.93M | 419.69M | 444.38M | 512.94M | 511.9M | 571.36M |
Days Sales Outstanding | 25.72 | 115.78 | 113.34 | 107.35 | 118.2 | 122.18 | 124.79 | 146.99 | 138.49 | 145.15 |
Inventory | 25.05M | 26.21M | 32.33M | 25.55M | 10.96M | 23.55M | 35.62M | 33.73M | 30.42M | 31.26M |
Days Inventory Outstanding | 77.29 | 74.98 | 73.36 | 63.66 | 30.78 | 60.8 | 85.22 | 87.62 | 69.35 | 72.24 |
Other Current Assets | 11.38M | 13.95M | 20.92M | 35.14M | 32.77M | 23.22M | 26.26M | 40.25M | 115.33M | 130.98M |
Total Non-Current Assets | 1.53B | 1.37B | 1.44B | 1.39B | 1.36B | 1.39B | 1.51B | 1.94B | 1.84B | 1.78B |
Property, Plant & Equipment | 485.27M | 514.18M | 537.43M | 618.48M | 601.51M | 560.01M | 521.78M | 518.15M | 503.81M | 502.29M |
Fixed Asset Turnover | 2.23x | 2.05x | 2.31x | 1.88x | 2.13x | 2.24x | 2.49x | 2.46x | 2.68x | 2.65x |
Goodwill | 311.09M | 327.98M | 334.83M | 336.94M | 340.69M | 365.15M | 408.41M | 533.21M | 529.9M | 530.3M |
Intangible Assets | 189.65M | 184.02M | 180.89M | 152.43M | 122.89M | 112.27M | 167.43M | 434.51M | 397.06M | 364.02M |
Long-Term Investments | 314.36M | 187.78M | 179.59M | 52.15M | 62.82M | 102.51M | 97.81M | 89.27M | 80.2M | 317M |
Other Non-Current Assets | 30.83M | 80.08M | 93.39M | 91.24M | 61.26M | 55.15M | 94.67M | 120.61M | 114.16M | 88.08M |
Total Assets | 2.54B▲ 0% | 2.87B▲ 12.9% | 2.82B▼ 1.5% | 2.94B▲ 4.0% | 3.12B▲ 6.3% | 2.7B▼ 13.5% | 2.99B▲ 10.8% | 3.13B▲ 4.5% | 3.23B▲ 3.1% | 3.19B▲ 0% |
Asset Turnover | 0.43x | 0.37x | 0.44x | 0.40x | 0.41x | 0.46x | 0.43x | 0.41x | 0.42x | 0.42x |
Asset Growth % | 9.69% | 12.88% | -1.54% | 4.02% | 6.31% | -13.47% | 10.82% | 4.54% | 3.1% | 17.7% |
Total Current Liabilities | 245.77M | 272.13M | 306.85M | 267.11M | 315.72M | 277.52M | 422.23M | 417.84M | 437.79M | 443.51M |
Accounts Payable | 14.37M | 21.92M | 15.21M | 12.62M | 17.78M | 14.17M | 20.93M | 17.38M | 17.84M | 8.67M |
Days Payables Outstanding | 44.34 | 62.73 | 34.52 | 31.44 | 49.91 | 36.59 | 50.06 | 45.15 | 40.66 | 34.26 |
Short-Term Debt | 0 | 0 | 0 | 15.82M | 15.4M | 13.26M | 13.63M | 12.24M | 0 | 0 |
Deferred Revenue (Current) | 23.15M | 17.47M | 19.99M | 15.44M | 18.47M | 18.59M | 31.5M | 31.64M | 31.38M | 144.12M |
Other Current Liabilities | 114.76M | 158.64M | 189.43M | 130.29M | 155.41M | 146.13M | 232.67M | 250.35M | 106.58M | 80.11M |
Current Ratio | 4.12x | 4.78x | 4.50x | 5.79x | 5.58x | 4.72x | 3.52x | 2.86x | 3.17x | 3.17x |
Quick Ratio | 4.01x | 4.69x | 4.40x | 5.70x | 5.54x | 4.64x | 3.44x | 2.78x | 3.10x | 3.10x |
Cash Conversion Cycle | 58.66 | 128.04 | 152.19 | 139.57 | 99.07 | 146.39 | 159.96 | 189.46 | 167.18 | 183.14 |
Total Non-Current Liabilities | 151.36M | 212.52M | 204.22M | 232.07M | 202.94M | 173.63M | 200.15M | 225.88M | 158.02M | 145.75M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 65.31M | 56.72M | 37.69M | 37.02M | 34.75M | 28.49M | 116.62M |
Deferred Tax Liabilities | 7.42M | 2.83M | 2.35M | 20.26M | 17.2M | 12.63M | 14.8M | 20.68M | 0 | 0 |
Other Non-Current Liabilities | 107.51M | 183.8M | 177.46M | 122.15M | 105.31M | 100.12M | 108.34M | 135.85M | 99.84M | 90.27M |
Total Liabilities | 397.14M | 497.71M | 511.07M | 499.18M | 518.66M | 451.15M | 622.38M | 643.72M | 595.81M | 589.25M |
Total Debt | 0 | 0 | 0 | 81.14M | 72.12M | 50.94M | 50.65M | 46.99M | 38.88M | 40.64M |
Net Debt | -634.37M | -925.25M | -805.59M | -998.84M | -1.16B | -577.43M | -767.32M | -530.76M | -663.01M | -603.21M |
Debt / Equity | - | - | - | 0.03x | 0.03x | 0.02x | 0.02x | 0.02x | 0.01x | 0.02x |
Debt / EBITDA | - | - | - | 0.26x | 0.17x | 0.16x | 0.14x | 0.13x | 0.11x | 0.12x |
Net Debt / EBITDA | -1.83x | -3.50x | -2.13x | -3.21x | -2.66x | -1.80x | -2.14x | -1.51x | -1.82x | -1.72x |
Interest Coverage | - | - | - | - | - | - | - | - | - | 65.71x |
Total Equity | 2.14B▲ 0% | 2.2B▲ 2.4% | 2.31B▲ 5.3% | 2.44B▲ 5.4% | 2.6B▲ 6.8% | 2.25B▼ 13.6% | 2.37B▲ 5.4% | 2.49B▲ 4.8% | 2.63B▲ 5.8% | 2.6B▲ 0% |
Equity Growth % | 8.34% | 2.44% | 5.32% | 5.42% | 6.8% | -13.56% | 5.38% | 4.84% | 5.83% | 22.02% |
Book Value per Share | 20.76 | 20.53 | 22.12 | 23.69 | 24.89 | 22.07 | 24.31 | 25.55 | 27.00 | 26.97 |
Total Shareholders' Equity | 2.14B | 2.19B | 2.31B | 2.43B | 2.6B | 2.25B | 2.36B | 2.48B | 2.62B | 2.59B |
Common Stock | 101K | 102K | 99K | 99K | 100K | 94K | 94K | 94K | 94K | 94K |
Retained Earnings | 2.08B | 2.14B | 2.33B | 2.44B | 2.61B | 2.3B | 2.39B | 2.5B | 2.63B | 2.6B |
Treasury Stock | - | - | - | - | - | 0 | - | 0 | 0 | 0 |
Accumulated OCI | -7.75M | -15.83M | -20.63M | -10.59M | -10.03M | -51.64M | -36.98M | -19.19M | -12.52M | -10.78M |
Minority Interest | 7.1M | 6.57M | 5.68M | 5.76M | 6.25M | 4.84M | 17.08M | 9.73M | 9.39M | 9.2M |
DLB Cash Flow Statement
Dolby Laboratories, Inc. (DLB) cash flow — operating, investing & free cash flow history
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 377.79M | 352.2M | 327.67M | 343.85M | 447.75M | 318.58M | 367.08M | 327.25M | 472.2M | 420.22M |
Operating CF Margin % | 34.93% | 33.4% | 26.39% | 29.6% | 34.95% | 25.41% | 28.24% | 25.69% | 35% | - |
Operating CF Growth % | 4.92% | -6.77% | -6.96% | 4.94% | 30.22% | -28.85% | 15.23% | -10.85% | 44.29% | 171.8% |
Net Income | 207.11M | 42.3M | 255.5M | 231.62M | 317.82M | 183.9M | 201.64M | 264.32M | 256.49M | 240.52M |
Depreciation & Amortization | 84.31M | 81.28M | 85.12M | 111.88M | 112.76M | 103.61M | 95.51M | 87.33M | 98.6M | 100.21M |
Stock-Based Compensation | 65.34M | 71.25M | 76.58M | 86.63M | 99.7M | 114.92M | 118.49M | 119.83M | 128.51M | 129.66M |
Deferred Taxes | -35.05M | 61.06M | -40.19M | -5.27M | -37.05M | -29.46M | -18.34M | -21.61M | 4.99M | 12.31M |
Other Non-Cash Items | 6.57M | 12.46M | 11.83M | 19.41M | -20.84M | 1.86M | 16.86M | -3.89M | 619K | -3.43M |
Working Capital Changes | 49.51M | 83.85M | -61.18M | -100.42M | -24.64M | -56.25M | -47.08M | -118.71M | -17.01M | -60.64M |
Change in Receivables | -62.08M | 97.63M | -57.2M | 35.55M | -70.19M | -8.01M | 48.13M | -37.67M | -1.78M | -56.5M |
Change in Inventory | -11.92M | -6.6M | -16.1M | -11.78M | 17.15M | -11.76M | -13.23M | -2.65M | 8.02M | 7.56M |
Change in Payables | 103.5M | -29.02M | 33.42M | -43.55M | 44.23M | 0 | 0 | 0 | 22.85M | -4.42M |
Cash from Investing | -158.03M | 78.09M | -56.23M | 134.37M | -44.91M | -295.94M | 54.21M | -286.29M | -10.59M | -1.2M |
Capital Expenditures | -99.62M | -72.81M | -96.28M | -66.35M | -54.45M | -47.93M | -30.34M | -30.01M | -36.35M | -34.2M |
CapEx % of Revenue | 9.21% | 6.9% | 7.75% | 5.71% | 4.25% | 3.82% | 2.33% | 2.36% | 2.69% | 2.55% |
Acquisitions | 0 | -22.85M | -14.92M | 0 | -4.5M | -38.17M | 25.7M | -487.88M | -1.36M | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -5.25M | -12.54M | -17.25M | -2.64M | 16.36M | -11.53M | 0 | 0 | 11.29M | 17.16M |
Cash from Financing | -106.83M | -133.63M | -385.28M | -207.78M | -252.51M | -610.56M | -236.81M | -287.81M | -247.24M | -311.5M |
Debt Issued (Net) | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
Equity Issued (Net) | -47.68M | -66.45M | -306.03M | -114.15M | -155.98M | -509.06M | -132.64M | -158.87M | -118.53M | -180.2M |
Dividends Paid | -57.06M | -66.16M | -77.5M | -88.58M | -89.17M | -100.07M | -103.41M | -114.58M | -126.6M | -129.39M |
Share Repurchases | -117.68M | -172.61M | -363.37M | -196.81M | -278.07M | -566.9M | -180.42M | -199.08M | -162.23M | -215.99M |
Other Financing | -2.09M | -1.02M | -1.76M | -5.04M | -7.36M | -1.44M | -766K | -14.36M | -2.11M | -1.92M |
Net Change in Cash | 114.61M▲ 0% | 290.88M▲ 153.8% | -119.66M▼ 141.1% | 274.39M▲ 329.3% | 153.05M▼ 44.2% | -604.66M▼ 495.1% | 189.59M▲ 131.4% | -240.21M▼ 226.7% | 215.61M▲ 189.8% | 115.91M▲ 0% |
Free Cash Flow | 272.93M▲ 0% | 266.85M▼ 2.2% | 214.14M▼ 19.8% | 274.86M▲ 28.4% | 393.3M▲ 43.1% | 259.12M▼ 34.1% | 336.74M▲ 30.0% | 297.25M▼ 11.7% | 430.26M▲ 44.7% | 379.68M▲ 0% |
FCF Margin % | 25.24% | 25.3% | 17.25% | 23.66% | 30.7% | 20.67% | 25.91% | 23.34% | 31.89% | 28.36% |
FCF Growth % | 97.37% | -2.23% | -19.75% | 28.36% | 43.09% | -34.12% | 29.96% | -11.73% | 44.75% | -3.86% |
FCF per Share | 2.64 | 2.49 | 2.05 | 2.67 | 3.76 | 2.54 | 3.45 | 3.05 | 4.41 | 3.93 |
FCF Conversion (FCF/Net Income) | 1.87x | 8.44x | 1.28x | 1.49x | 1.44x | 1.73x | 1.83x | 1.25x | 1.85x | 1.58x |
Interest Paid | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
Taxes Paid | 56.76M | 60.88M | 59.72M | 52.87M | 70.74M | 40.34M | 61.48M | 63.22M | 73.74M | -10.61M |
DLB Key Ratios
Dolby Laboratories, Inc. (DLB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 9.79% | 1.92% | 11.32% | 9.74% | 12.3% | 7.58% | 8.68% | 10.78% | 9.96% | 9.22% |
Return on Invested Capital (ROIC) | 13.21% | 9.88% | 15.85% | 11.23% | 17.73% | 10.45% | 12.02% | 11.15% | 10.13% | 9.68% |
Gross Margin | 89.06% | 87.9% | 87.04% | 87.39% | 89.85% | 88.73% | 88.26% | 88.97% | 88.13% | 87.86% |
Net Margin | 18.66% | 3.96% | 20.55% | 19.91% | 24.21% | 14.68% | 15.44% | 20.56% | 18.9% | 17.97% |
Debt / Equity | - | - | - | 0.03x | 0.03x | 0.02x | 0.02x | 0.02x | 0.01x | 0.02x |
Interest Coverage | - | - | - | - | - | - | - | - | - | 65.71x |
FCF Conversion | 1.87x | 8.44x | 1.28x | 1.49x | 1.44x | 1.73x | 1.83x | 1.25x | 1.85x | 1.58x |
Revenue Growth | 5.43% | -2.48% | 17.73% | -6.43% | 10.28% | -2.14% | 3.67% | -2% | 5.92% | 1.8% |
Related:DLB Dividend History·DLB Revenue History·DLB Price History·DLB P/E History·DLB Financial Ratios·DLB Institutional Holders
DLB SEC Filings & Documents
Dolby Laboratories, Inc. (DLB) SEC filings — annual & quarterly reports (10-K, 10-Q)
DLB Frequently Asked Questions
Dolby Laboratories, Inc. (DLB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Dolby Laboratories, Inc. (DLB) reported $1.34B in revenue for fiscal year 2025. This represents a 516% increase from $217.5M in 2003.
Dolby Laboratories, Inc. (DLB) grew revenue by 5.9% over the past year. This is steady growth.
Yes, Dolby Laboratories, Inc. (DLB) is profitable, generating $240.5M in net income for fiscal year 2025 (18.9% net margin).
Dividend & Returns
Yes, Dolby Laboratories, Inc. (DLB) pays a dividend with a yield of 2.48%. This makes it attractive for income-focused investors.
Dolby Laboratories, Inc. (DLB) has a return on equity (ROE) of 10.0%. This is below average, suggesting room for improvement.
Dolby Laboratories, Inc. (DLB) generated $379.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.